Blindsided: challenging the dogma of masking in clinical trials
- PMID: 32020896
- DOI: 10.1136/bmj.m229
Blindsided: challenging the dogma of masking in clinical trials
Conflict of interest statement
The BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare the following other interests: In the past three years, AMD has been a consultant for Sanofi, RTI Health Solutions, Eczema Society of Canada, and Canadian Agency for Drugs and Technology in Health. He has received honorariums from Prime, CME Outfitters, and Eczema Society of Canada. His institution has received educational grants from Sanofi and research grants from Sanofi and Regeneron.
Comment on
-
Impact of blinding on estimated treatment effects in randomised clinical trials: meta-epidemiological study.BMJ. 2020 Jan 21;368:l6802. doi: 10.1136/bmj.l6802. BMJ. 2020. PMID: 31964641 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical